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Background
Kaposi disease (KD) displays polymorphic manifesta-
tions, ranging from minimal cutaneous involvement to
extensive visceral disease. Its clinical outline is different
in HIV-positive patients compared to the classical non-
HIV-related form that is diagnosed more often in elderly
patients without other significant immune impairment.
Methods
A retrospective study on KD was performed in two aca-
demic centers, tertiary-care hospitals with national
addressability in Romania. Two groups were compara-
tively studied: HIV-infected patients diagnosed in the
National Institute for Infectious Diseases “Prof.Dr. Matei
Balş” (HIV-positive group), and non-HIV patients diag-
nosed in the first Clinic of Dermatology, Colentina Clin-
ical Hospital (HIV-negative group). The statistical
analysis was performed using IBM SPSS Statistics v.22
(Chicago, USA).
Results
A total number of 71 cases, 30 in the HIV-positive
group and 41 in the HIV-negative group were identified.
The non-HIV patients were benign European form and
immunosuppressed other than HIV, respectively. There
was a male predominance, with a male-to-female ratio
in HIV-positive and HIV-negative patients of 2:1 and
4.1:1 respectively. The mean age at KD diagnosis was
41.6±15.0 years in HIV-positive and 70.2±11.8 years in
HIV-negative patients.
The mean number of comorbidities was 3 in the HIV-
positive group compared to 1 in HIV-negative, p =
0.011). In the HIV-positive group, 17 patients (56.7%)
were classified Mitsuyasu stage 1, 6 (20%) stage 2, 2
(6.7%) stage 3 and 5 (16.7%) stage 4. In the HIV-nega-
tive group, all 41 patients were Mitsuyasu stage 1.
In the HIV-positive group all patients received antiretro-
viral therapy and only 6 (20%) received other types of tar-
geted therapy for KD: topical (5, 16.7%), systemic (5,
16.7% – interferon, etc.), chemotherapy (2, 6.7%), local
radiotherapy (2, 6.7%). In the HIV-negative group, all
patients received specific treatment, such as: topical (24,
58.5%), systemic (14, 34.1% – dapsone, pentoxifylline),
chemotherapy (2, 4.9%), local radiotherapy (7, 17.1%), elec-
trocauterization (15, 36.6%), surgical excision (4, 9.8%).
Loss for follow-up appeared to be less frequent in the
HIV-positive group (7 patients, 35%) than in the HIV-
negative group (35 patients, 85.4%) but occurred faster
in the HIV-positive group, after a mean interval of 8.6 ±
3.4 vs. 15.9 ± 37.3 months in HIV-negative group. Over-
all survival was 60% (HIV-positive) and 100% (HIV-
negative).
Conclusion
This work has identified two different outlines of KD, an
aggressive progression with high mortality in HIV-posi-
tive patients, and a gradual progression, with virtually
no short-term mortality, in elderly patients. In the HIV-
positive group, very few patients received other types of
treatment for KD, apart from antiretroviral therapy.* Correspondence: oanasandulescu1@gmail.com1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
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